Cancer Biomarkers & Screening

A malignancy biomarker alludes to a substance or procedure that is characteristic of the nearness of disease in the body. A biomarker might be an atom emitted by a tumor or a particular reaction of the body to the nearness of malignant growth. Hereditary, epigenetic, proteomic, glycomic, and imaging biomarkers can be utilized for malignancy finding, guess, and the study of disease transmission. In a perfect world, such biomarkers can be tested in non-intrusively gathered biofluids like blood or serum

    Related Conference of Cancer Biomarkers & Screening

    November 19-20, 2026

    44th World Cancer Conference

    Dubai, UAE
    November 23-24, 2026

    8th International Conference on Women Oncology

    Miami, USA
    November 23-24, 2026

    7th Cancer Diagnostics & Treatment Conference

    Miami, USA
    November 24-25, 2026

    6th International Conference on Oncology and Cancer

    Paris, France
    December 03-04, 2026

    10th Global Meeting on Oncology and Radiology

    Madrid, Spain
    December 08-09, 2026

    14th Euro Breast Cancer and Therapeutics

    Paris, France
    December 08-09, 2026

    27th World Congress on Cancer Summit

    Paris, France
    February 15-16, 2027

    5th World Congress on Oral Cancer

    Singapore City, Singapore
    April 15-16, 2027

    12th World Conference on Breast and Cervical Cancer

    Amsterdam, Netherlands
    April 27-28, 2027

    37th Experts Meet On Cancer Research & Therapy

    Paris, France
    May 05-06, 2027

    7th World Congress on Breast Cancer

    Berlin, Germany
    May 05-06, 2027

    23rd International Conference on Cancer Research

    Berlin, Germany

    Cancer Biomarkers & Screening Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in